LIXA has a mission to solve antimicrobial resistance (AMR) for anyone, anything, anywhere. We focus on developing scalable universal antimicrobial resistance breakers and antibiofilm technologies to reverse resistance and re-instate the effectiveness of the full existing antimicrobial arsenal.
Headquarters:
Australia
Company Type:
SME
Company size:
11-50 Employees
Year Founded:
2021 (4 years)
Address:
22 STIRLING HWY; NEDLANDS, WESTERN AUSTRALIA 6009, AU
LOW
spending power
